High susceptibility to experimental myopia in a mouse model with a retinal on pathway defect - Wikidata - awgldk - TriplyDB

High susceptibility to experimental myopia in a mouse model with a retinal on pathway defect

High susceptibility to experimental myopia in a mouse model with a retinal on pathway defect

http://www.wikidata.org/entity/Q37363546

about

RPE and Choroid Mechanisms Underlying Ocular Growth and Myopia Light levels, refractive development, and myopia--a speculative review Adenomatous Polyposis Coli Mutation Leads to Myopia Development in Mice A Head-Mounted Spectacle Frame for the Study of Mouse Lens-Induced Myopia.Potassium channel and NKCC cotransporter involvement in ocular refractive control mechanisms Vision-guided ocular growth in a mutant chicken model with diminished visual acuity Analysis of postnatal eye development in the mouse with high-resolution small animal magnetic resonance imaging.Exaggerated eye growth in IRBP-deficient mice in early development Refractive index measurement of the mouse crystalline lens using optical coherence tomography.Pharmacologically stimulated pupil and accommodative changes in Guinea pigs.Genetic deletion of the adenosine A2A receptor confers postnatal development of relative myopia in mice.Ketamine-xylazine anesthesia causes hyperopic refractive shift in mice Comparison of refractive development and retinal dopamine in OFF pathway mutant and C57BL/6J wild-type mice Visually-driven ocular growth in mice requires functional rod photoreceptors Investigating mechanisms of myopia in mice.Rapid, accurate, and non-invasive measurement of zebrafish axial length and other eye dimensions using SD-OCT allows longitudinal analysis of myopia and emmetropization.Reproducibility and age-related changes of ocular parametric measurements in rabbits Image defocus and altered retinal gene expression in chick: clues to the pathogenesis of ametropia ON pathway mutations increase susceptibility to form-deprivation myopia.Experimental murine myopia induces collagen type Iα1 (COL1A1) DNA methylation and altered COL1A1 messenger RNA expression in sclera.Neonatal aphakia is associated with altered levels of dopamine metabolites in the non-human primate retina.Pharmacology of myopia and potential role for intrinsic retinal circadian rhythms.Photopic visual input is necessary for emmetropization in mice.Altered Refractive Development in Mice With Reduced Levels of Retinal Dopamine IRBP deficiency permits precocious ocular development and myopia.Sequence variations of GRM6 in patients with high myopia.The rat with oxygen-induced retinopathy is myopic with low retinal dopamine Genome-Wide Scleral Micro- and Messenger-RNA Regulation During Myopia Development in the Mouse.The Transduction Cascade in Retinal ON-Bipolar Cells: Signal Processing and Disease.Molecular and Biochemical Aspects of the Retina on Refraction.Animal models in myopia research.Association of Body Length with Ocular Parameters in Mice.Dopamine signaling and myopia development: What are the key challenges.Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness.The effect of topical administration of cyclopentolate on ocular biometry: An analysis for mouse and human models.Assessment of axial length measurements in mouse eyes.Variational analysis of the mouse and rat eye optical parameters Refractive Development in the "ROP Rat".Retinal degeneration increases susceptibility to myopia in mice.Neuronal mechanisms underlying differences in spatial resolution between darks and lights in human vision.

P2860

Q26796695-C30336E7-00B8-498C-A1F6-6E0BBE07D96F Q27013720-BDE2B92F-3260-43F6-914D-E37A57F7191C Q27312140-77790968-DDDD-4848-A5AA-BE241BD50D20 Q27349342-B183FFF5-83AA-4CC8-B912-681D8EA6F328 Q28473235-E5DB5729-003A-45D8-A75B-83B085A96D21 Q30449906-8612FFA6-6C5A-4F17-B885-630F574409D7 Q33689455-D113DB2B-A688-4DB8-851D-E5C604F152A3 Q33923297-BC143C77-4351-47CD-AF3B-73009A2509F8 Q34002075-C11AA6E6-18E9-40B5-AA79-C4861CA894E6 Q34107588-463216B6-CA51-4156-82D8-6511E42A9EA7 Q34135461-EA6D1A87-6AF0-404D-8F5B-D2EDA40118A4 Q34188532-A1A2BC29-B317-4100-ADAC-BAEEA2AFA573 Q34217056-C82F9672-EC7F-4BD8-97D2-1EE26EAC4955 Q34312169-CE0DB197-104E-450A-97C6-3C86BD03AA2C Q34321984-2450BA71-4D4D-451C-9FCA-C72B743CCE2C Q34380257-A6C8EA74-6E6E-4282-B86A-3981D1D55D7F Q34383531-A922BE94-8B9B-4BB8-8905-53910F89A6AB Q35221317-D8090D22-D36A-47E1-9A1D-D1FC4E35EA12 Q35912112-7A9A7AA6-AEFD-4136-8648-F677DD8C9436 Q36015813-514A7DC8-C31C-4EF8-8822-7B3A432D0F1B Q36220135-6DEF7065-ECD1-4B76-BF08-F0E7DD91CF1E Q36794501-E8958252-4B07-4B6A-A9A1-C68BD418449E Q37227969-83C8D2EE-D099-47B3-8B02-3D8F3C554CCE Q37242113-B795865C-B3EF-49B2-A115-DBDD86CCC878 Q37371333-390E0661-319B-4A76-B41C-4AC0C79CE90E Q37395103-07D8E4C2-FED0-4495-95FE-AC9E771CBEE7 Q37406617-C93EFBCC-4B30-4D0C-BEEE-0720754EEEBE Q37407573-81D1A9BC-2B09-4611-A73A-ECF5060E549A Q38429824-BA6DF3E2-CD3C-4DC3-B104-01D5AFE570ED Q38574373-A78B294E-9B70-4442-9EFC-193410615B13 Q38697288-7F87F6AE-7CBA-4BB0-9A1D-D4567C7D4E94 Q38779260-32C0CB9D-1DE4-49FC-B092-7E47D792474A Q39365259-0CAC7203-1020-4EAC-86F7-DEEEEBD1EB87 Q41449349-380C5DC8-7203-4CE0-BA20-92B1CE3A78C6 Q41565463-8EF05ADB-7A0A-43F3-9556-D6C4F0DA0789 Q41814070-86AE3BED-2405-4064-9894-8EFA620E045A Q41962467-C15EDE6B-5AE3-4FC8-A67B-C6A9411A6EDC Q42577238-EA2A48A3-4369-4C16-987A-D445D872C5AE Q42963793-F7C7728B-F123-48DD-9F50-6D3BDC1A3CCD Q47101887-51EDCA9D-D17F-4090-8994-8DAA4B523B97

P2860

High susceptibility to experimental myopia in a mouse model with a retinal on pathway defect

http://www.wikidata.org/entity/Q37363546

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

High susceptibility to experim ...... th a retinal on pathway defect

@en

High susceptibility to experim ...... h a retinal on pathway defect.

@nl

type

label

High susceptibility to experim ...... th a retinal on pathway defect

@en

High susceptibility to experim ...... h a retinal on pathway defect.

@nl

prefLabel

High susceptibility to experim ...... th a retinal on pathway defect

@en

High susceptibility to experim ...... h a retinal on pathway defect.

@nl

P1433

Q37363546-B5E54C36-3149-40A0-A502-F51EE0FDDB74

P1476

Q37363546-8A14F024-1E2A-45C5-ACB9-EE34CBA18861

P2093

Q37363546-05E64163-C3E7-403C-9560-14FD44EBC4F7

Q37363546-0BF47EF9-97EB-4519-BEF7-B0828ED104F7

Q37363546-0CB1E059-456E-4799-891F-EA5C8289F625

Q37363546-1D46812B-4E68-46AF-B19C-BF47AC9C0D8F

Q37363546-28E9AC68-8FE5-471D-BB27-04D7391685F0

Q37363546-3DCBCEA4-149D-46E4-AD0C-573D6149875C

Q37363546-7D61D014-C603-47F9-8E4D-14D706300FB8

P2860

Q37363546-035E3462-7CA5-47CE-8048-39EC9D127C07

Q37363546-0787A24B-597D-4A60-8836-ECA9527AE7B8

Q37363546-07D5EC3D-6AE1-42EE-920E-4F39D6E4786E

Q37363546-08264A82-5997-4CD7-875D-FFB2CE198D3E

Q37363546-09A772D6-C140-48F2-83FB-E274343ABCD9

Q37363546-0A632DBD-6289-4BB4-822A-9F5412D7B1C8

Q37363546-0BA9FF28-940D-4FB3-926F-0C77AC1E2C34

Q37363546-0C380315-54BE-4C40-B63D-EBFA7B40D359

Q37363546-10ECC6B4-756B-4C14-ACED-995BB0A3DC06

Q37363546-185B2401-E9FB-4550-891E-A63F63D34BDD

P304

Q37363546-1A3D961E-CEFF-40DA-A88C-C5059D772526

P31

Q37363546-6BD0C6D2-0882-468A-926F-11DE2F8A20A9

P356

Q37363546-CA3C6AD6-BCB8-4A2E-996B-31CCF379B480

P407

Q37363546-7FD54EE0-EEB0-4DB6-B048-36E4068CF759

P433

Q37363546-7BF4F1F0-95AA-4BE3-BADA-FB2A06B218B0

P478

Q37363546-EAE5811B-C9C4-40C9-B2B7-9F3546450ACD

P50

Q37363546-E17C8C23-B70B-442A-B249-A0703A691AF3

P577

Q37363546-5A6AEABA-C029-4834-84E0-4EC81C4E6BA1

P5875

Q37363546-D66180A6-C8D3-4D39-AB5D-26BE34A355FE

P698

Q37363546-3F7D6CD9-97F2-40CC-8FA7-2FA4A30B5668

P921

Q37363546-20E2D735-D187-47C1-9B47-861BD5F45520

P932

Q37363546-182E225B-B2C9-42E5-9EFE-3A4F5E9F4444

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

High susceptibility to experim ...... th a retinal on pathway defect

@en

P2093

Alcides Fernandes

http://www.w3.org/2001/XMLSchema#string

Amanda E Faulkner

http://www.w3.org/2001/XMLSchema#string

Frank Schaeffel

http://www.w3.org/2001/XMLSchema#string

Hang Yin

http://www.w3.org/2001/XMLSchema#string

Machelle T Pardue

http://www.w3.org/2001/XMLSchema#string

Nikita Pozdeyev

http://www.w3.org/2001/XMLSchema#string

P Michael Iuvone

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness

Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness

Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein.

Mutations in NYX of individuals with high myopia, but without night blindness

The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein

Identification of the gene and the mutation responsible for the mouse nob phenotype

TGFbeta-induced factor: a candidate gene for high myopia

Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina

In vivo biometry in the mouse eye with low coherence interferometry.

Retinal dopamine and form-deprivation myopia.

P304

706-712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.07-0643

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Robert W. Williams

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5617019

http://www.w3.org/2001/XMLSchema#string

P698

18235018

http://www.w3.org/2001/XMLSchema#string

P921

P932

2752325

http://www.w3.org/2001/XMLSchema#string